TRIB

Trinity Biotech
TRIB

Overview Fund Activity

75 hedge funds and large institutions have $318M invested in Trinity Biotech in 2013 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 21 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
+5
Holders Change %
+7.14%
% of All Funds
2.18%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
14
Increased
30
Reduced
21
Closed
8
Calls
$885K
Puts
$704K
Net Calls
+$181K
Net Calls Change
-$24K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$66.6M
2
CCMLC
2
Cardinal Capital Management LLC (Connecticut)
Connecticut
$14.1M
3
PC
3
Pier Capital
Connecticut
$7.04M
4
UCFA
4
United Capital Financial Advisors
Texas
$3.69M
5
Arrowstreet Capital
5
Arrowstreet Capital
Massachusetts
$3.48M

Top Sellers

1
William Blair & Company
1
William Blair & Company
Illinois
$17M
2
GPP
2
Great Point Partners
Connecticut
$0
3
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$6.7M
4
CIP
4
Chartwell Investment Partners
Pennsylvania
$10.1M
5
OSAM
5
O'Shaughnessy Asset Management
Connecticut
$989K
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
76
BBT Capital Management
Texas
– -$1.61M -14,760 Closed
CCM
77
Corsair Capital Management
New York
– -$1.13M -10,394 Closed
Boston Partners
78
Boston Partners
Massachusetts
– -$743K -6,825 Closed
LOM
79
Loeb Offshore Management
New York
– -$264K -2,429 Closed
SFM
80
Systematic Financial Management
New Jersey
– -$144K -1,332 Closed
Bank of Montreal
81
Bank of Montreal
Ontario, Canada
– -$9K -78 Closed
CAM
82
ClariVest Asset Management
California
– -$8K -77 Closed
1 2 3
4